What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
The scientist’s investigation covers issues in Immunology, Pathology, Lymphoma, Reed–Sternberg cell and Molecular biology.
His Immunology research includes themes of Haematopoiesis and Transplantation.
Sibrand Poppema has researched Pathology in several fields, including Immunoglobulin D, Germinal center and Immunoperoxidase.
His Lymphoma research incorporates elements of Stage, Cancer research, B cell and Virology.
The various areas that Sibrand Poppema examines in his Reed–Sternberg cell study include Epstein–Barr virus, Diffuse large B-cell lymphoma, Nodular sclerosis, Human leukocyte antigen and Hodgkin's lymphoma.
His Antigen study combines topics from a wide range of disciplines, such as Cytotoxic T cell, T cell, Antigen-presenting cell and Antibody.
His most cited work include:
- Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell cytotoxicity (643 citations)
- BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. (615 citations)
- DISTRIBUTION OF T-CELL SUBSETS IN HUMAN LYMPH-NODES (365 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Pathology, Immunology, Molecular biology, Antigen and Cancer research.
His research integrates issues of Immunophenotyping, Germinal center and Lymphocyte in his study of Pathology.
His Immunology study frequently intersects with other fields, such as Transplantation.
The concepts of his Molecular biology study are interwoven with issues in Cell culture, T cell, B cell, microRNA and Hairy cell leukemia.
His Antigen research integrates issues from Cytotoxic T cell and Antibody, Monoclonal antibody.
His studies deal with areas such as Epstein–Barr virus, Cytokine and Hodgkin's lymphoma as well as Reed–Sternberg cell.
He most often published in these fields:
- Pathology (33.51%)
- Immunology (31.68%)
- Molecular biology (23.04%)
What were the highlights of his more recent work (between 2006-2018)?
- Immunology (31.68%)
- Molecular biology (23.04%)
- Cancer research (17.80%)
In recent papers he was focusing on the following fields of study:
Sibrand Poppema mainly investigates Immunology, Molecular biology, Cancer research, Reed–Sternberg cell and B cell.
His biological study spans a wide range of topics, including Allele and Allele frequency.
His biological study spans a wide range of topics, including Cell culture, Cell growth, Gene, Regulatory T cell and Cytotoxic T cell.
His Cancer research research is multidisciplinary, incorporating perspectives in T cell, Diffuse large B-cell lymphoma, Hodgkin lymphoma, Hodgkin's lymphoma and Cell cycle.
Sibrand Poppema is investigating Reed–Sternberg cell as part of his inquiry into Lymphoma and Pathology.
Sibrand Poppema has researched Pathology in several fields, including Angiogenesis and Lymphocyte.
Between 2006 and 2018, his most popular works were:
- Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell cytotoxicity (643 citations)
- Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma (126 citations)
- Hodgkin Lymphoma Cell Lines Are Characterized by a Specific miRNA Expression Profile (120 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
His scientific interests lie mostly in Immunology, Reed–Sternberg cell, Molecular biology, Lymphoma and B cell.
His Immunology study combines topics from a wide range of disciplines, such as Allele and Allele frequency.
His Molecular biology research incorporates elements of Cell culture, Genome, Gene and In vivo.
Lymphoma is a subfield of Internal medicine that he tackles.
His B cell study integrates concerns from other disciplines, such as Cancer research, microRNA, Chronic lymphocytic leukemia and Rituximab.
His HLA-A research focuses on Virus and how it connects with Antigen.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
